https://wsxzaq.shinyapps.io/wsxzaq_nomogram/). The score has been verified among three independent external cohorts (GSE13213, GSE68465 and GSE72094), and is still an independent risk factor for lung adenocarcinoma. In addition, among the other 6 cancers, the OS prognosis of high and low-risk groups of PRS is different (P < 0.05). Our research results have screened multiple platelet differential genes with clinical significance and constructed a meaningful prognostic risk score (PRS)." name="description"> Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression - Figure f2 | Aging
← Back
Research Paper Volume 13, Issue 6 pp 8706—8719

Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression

class="figure-viewer-img"

Figure 2. The prognostic value of PRS (platelet receptor-related risk score). (A–D) Kaplan-Meier curves of overall survival based on the PRS in the TCGA, GSE13213, GSE68465 and GSE72094 cohort (E–H) Multivariate Cox regression analysis in the TCGA, GSE13213, GSE68465 and GSE72094 cohort.